| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/19/2002 | WO2002072034A2 Chronotherapeutic dosage forms |
| 09/19/2002 | WO2002072033A2 Chronotherapeutic dosage forms containing glucocorticosteroid |
| 09/19/2002 | WO2002072026A2 In situ langerhans cell vaccine |
| 09/19/2002 | WO2002072018A2 A cream-t0-powder dermatological composition |
| 09/19/2002 | WO2002072011A2 Stabilized therapeutic and imaging agents |
| 09/19/2002 | WO2002072010A2 Taxane prodrugs |
| 09/19/2002 | WO2002071994A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/19/2002 | WO2002055057A3 Treatment of asthma and other lung conditions |
| 09/19/2002 | WO2002053617B1 Linear block polymer |
| 09/19/2002 | WO2002053554A3 Tetraether lipid derivatives and liposomes containing tetraether lipid derivatives and lipid agglomerates and the use thereof |
| 09/19/2002 | WO2002049624A3 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
| 09/19/2002 | WO2002043685A3 Cosmetic and/or pharmaceutical emulsions |
| 09/19/2002 | WO2002038577A3 Extended release erythromycin derivatives |
| 09/19/2002 | WO2002038137A3 Skin friendly active ingredient plaster for transdermal administration of rubefacient active ingredients |
| 09/19/2002 | WO2002036140A3 Use of a preparation of cimicifuga racemosa |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/19/2002 | WO2002024158A3 Pulmonary delivery in treating disorders of the central nervous system |
| 09/19/2002 | WO2002020018A8 Tablets containing epinastine manufactured by direct compression |
| 09/19/2002 | WO2002009864A9 Encapsulation of liquid template particles |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002002189A3 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 09/19/2002 | WO2001097779A3 Improved injectable dispersions of propofol |
| 09/19/2002 | WO2001083521A3 Reductive alkylation process on glycopeptides |
| 09/19/2002 | WO2001080902A3 A particulate complex for administering nucleic acid into a cell |
| 09/19/2002 | WO2001070221A1 Sustained release oral preparations |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | WO2000009639A3 Fatty ester combinations |
| 09/19/2002 | US20020133235 Cell-culture and polymer constructs |
| 09/19/2002 | US20020133019 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition |
| 09/19/2002 | US20020132982 Complexing antihemophila factor in fluid; obtain antihemophila protein, adjust protein conformation, bind to stabilizer, monitor activity |
| 09/19/2002 | US20020132854 Long acting antidepressant microparticles |
| 09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 09/19/2002 | US20020132850 Multilayer tablet for administering a fixed combination of tramadol and diclofenac |
| 09/19/2002 | US20020132839 Are at least 1.2 times more bioavailable than conventional valsartan capsule. |
| 09/19/2002 | US20020132827 Using full D1 dopamine receptor agonists in an intermittent dosing protocol with a short, but essential, "off-period." |
| 09/19/2002 | US20020132825 Analgesic combination of oxycodone and celecoxib |
| 09/19/2002 | US20020132805 Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine |
| 09/19/2002 | US20020132803 Fluticasone propionate, an antimicrobial preservative, a surfactant, a tonicity agent, and a suspending agent; pump spray devices. |
| 09/19/2002 | US20020132793 Use of methylphenidate compounds to enhance memory |
| 09/19/2002 | US20020132790 Pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives |
| 09/19/2002 | US20020132787 Compositions and methods for nucleic acid delivery to the lung |
| 09/19/2002 | US20020132781 Optionally a glutathione pathway enhancing and detoxifying compound, particularly cystine |
| 09/19/2002 | US20020132780 Gelatin, cartilage, aminosugars, glycosaminoglycans, dimethyl sulfone or precursors, or S-adenosylmethionine; sweetening agent; and water; treating joint and bone dysfunction and inflammation. |
| 09/19/2002 | US20020132773 Methods for reducing fat by administration of adiponectin |
| 09/19/2002 | US20020132770 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 09/19/2002 | US20020132764 Cyclosporin; mycophenolic acid or its salt as an immunosuppressor; and rapamycin or a derivative |
| 09/19/2002 | US20020132757 Formulations for administering calcitonin and processes for preparing the same |
| 09/19/2002 | US20020132756 May be used as food and feed ingredients, which are easily handed and packaged with longer shelf life. In ruminant feed, the encapsulated products may have the by-pass function. |
| 09/19/2002 | US20020132750 Cleanser |
| 09/19/2002 | US20020132015 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 09/19/2002 | US20020132011 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
| 09/19/2002 | US20020132010 Divalproex sodium dosage forms and a process for their production |
| 09/19/2002 | US20020132009 Entacapone, nitecapone, or salts thereof and croscarmellose sodium to increase the release rate; catechol-O-methyl transferase inhibitors |
| 09/19/2002 | US20020132008 Gel of a solvent vehicle, water-insoluble swellable mucoadhesive polymer, a pH sensitive film-forming polymer and a molecule of interest |
| 09/19/2002 | US20020132007 Sustainded-release composition including amorphous polymer |
| 09/19/2002 | US20020132006 Odor-masking coating for a pharmaceutical preparation |
| 09/19/2002 | US20020132005 Combined diffusion / osmotic pumping drug delivery system |
| 09/19/2002 | US20020132004 Anti-inflammatory pharmaceutical formulations |
| 09/19/2002 | US20020132003 Outer layer of time delayed coating and core of active substance to assist in the waking process of human sleep cycle |
| 09/19/2002 | US20020132002 Water soluble medicament, polymer mixture comprising polyvinyl acetate combined with polyvinyl pyrrolidone, cellulose ether polymer |
| 09/19/2002 | US20020132001 Delayed-release formulation of aldosterone antagonist drug which when orally administered 6-12 hours prior to acrophase provides profile of plasma drug concentration corresponding to diurnal cycle of plasma aldosterone concentration |
| 09/19/2002 | US20020131999 Using stearic acid or zinc stearate as lubricant |
| 09/19/2002 | US20020131998 Rapidly dissolving dosage form and process for making same |
| 09/19/2002 | US20020131996 Methods and compositions for blocking microbial adherence to eukaryotic cells |
| 09/19/2002 | US20020131995 Drug delivery system comprising delivery vehicle having low molecular weight hyaluronan ligand with affinity for CD44 receptors |
| 09/19/2002 | US20020131994 Comprising active substance in combination with a biopolymer; transdermal delivery of active substance |
| 09/19/2002 | US20020131993 Gel, ointment, solution, suspension or film containing mixture of nicotine and an uncrosslinked, water-insoluble vinypyrrolidone copolymer with hydrophobic comonomer for sustained transdermal delivery of nicotine; smoking-cessation |
| 09/19/2002 | US20020131990 Pullulan free edible film compositions and methods of making the same |
| 09/19/2002 | US20020131988 Provides flexibility in adjusting release of medicament; faster onset of release can be provided along with a long-term sustained-release |
| 09/19/2002 | US20020131987 Method for enhancing stable cellular creatine concentration |
| 09/19/2002 | US20020131953 In situ langerhans cell vaccine |
| 09/19/2002 | US20020131952 Biodegradation, time-release agents, drug delivery |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | US20020131943 Hair cap with conditioner or other hair conditioning agent |
| 09/19/2002 | US20020130430 Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products |
| 09/19/2002 | DE10112651A1 Inhomogene Kieselsäuren als Trägermaterial Inhomogeneous silicas as carrier material |
| 09/19/2002 | DE10111843A1 Verbindungen zur Behandlung von inflammatorischen Erkrankungen Compounds for the treatment of inflammatory disorders |
| 09/19/2002 | DE10111230A1 Metallorganische Gerüstmaterialien und Verfahren zu deren Herstellung Organometallic framework materials and processes for their preparation |
| 09/19/2002 | DE10110953A1 Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten Transdermal therapeutic system for administration of partial dopamine-D2 agonists |
| 09/19/2002 | DE10108857A1 Bioaktive und biokompatible Konjugate mit magnetischen Eigenschaften und Verfahren zu deren Herstellung Bioactive and biocompatible conjugates with magnetic properties and methods for their preparation |
| 09/19/2002 | CA2441854A1 Composition for rectal delivery of an oxazolidinone antibacterial drug |
| 09/19/2002 | CA2440935A1 Micellar drug delivery vehicles and precursors thereto and uses thereof |
| 09/19/2002 | CA2440675A1 Composition containing asiasari radix extracts for protecting brain cells and improving memory |
| 09/19/2002 | CA2440641A1 Chronotherapeutic dosage forms containing glucocorticosteroid |
| 09/19/2002 | CA2440412A1 Taste masked liquid pharmaceutical compositions |
| 09/19/2002 | CA2440225A1 Taxane prodrugs |
| 09/19/2002 | CA2440209A1 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 09/19/2002 | CA2440167A1 Method to prepare microparticles that contain metoprolol |
| 09/19/2002 | CA2440163A1 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 09/19/2002 | CA2440158A1 Method to obtain microparticles containing a h+, k+-atp-ase inhibitor |
| 09/19/2002 | CA2440144A1 Methods for reducing fat by administration of adiponectin |
| 09/19/2002 | CA2439953A1 Stabilized therapeutic and imaging agents |
| 09/19/2002 | CA2439925A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/19/2002 | CA2439301A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 09/19/2002 | CA2438401A1 Pharmaceutical composition |
| 09/19/2002 | CA2438065A1 Skin care products with improved skin and material softness |
| 09/19/2002 | CA2437746A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/19/2002 | CA2434762A1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | CA2403380A1 Sustained release oral preparations |